Hwail Pharm Non-Executive Director Jeong Jeong-cheol Sees 90% Share Reduction Due to Stock Consolidation, No Change in Ownership Percentage

Hwail Pharm's non-registered executive Jeong Jeong-cheol saw his shareholding decrease by 14,610 shares from 16,233 to 1,623 due to a stock consolidation on April 9, 2026.
This is a routine adjustment from a reverse stock split, where total outstanding shares also decreased proportionally, leaving his ownership percentage unchanged at 0.02%.
No new capital raising or dilution occurs, posing no impact on existing shareholder value.
[AI Summary]This change is a formal adjustment from a stock consolidation with no effect on shareholder equity or control. The absence of capital allocation or dilution makes this a neutral event for investment risk.